Dapiprazole en es it fr

Dapiprazole Brand names, Dapiprazole Analogs

Dapiprazole Brand Names Mixture

  • No information avaliable

Dapiprazole Chemical_Formula


Dapiprazole RX_link

No information avaliable

Dapiprazole fda sheet

Dapiprazole msds (material safety sheet)

Dapiprazole MSDS

Dapiprazole Synthesis Reference

No information avaliable

Dapiprazole Molecular Weight

325.451 g/mol

Dapiprazole Melting Point

No information avaliable

Dapiprazole H2O Solubility


Dapiprazole State


Dapiprazole LogP

No information avaliable

Dapiprazole Dosage Forms

Ophthalmic solution (eye drops, 0.5%); Ophthalmic powder for reconstitution (0.5%)

Dapiprazole Indication

Used in the treatment of iatrogenically induced mydriasis produced by adrenergic (phenylephrine) or parasympatholytic (tropicamide) agents used in certain eye examinations.

Dapiprazole Pharmacology

Dapiprazole is an alpha-adrenergic blocking agent. It produces miosis by blocking the alpha-adrenergic receptors on the dilator muscle of the iris. Dapiprazole produces no significant action on ciliary muscle contraction and thus, there are no changes in the depth of the anterior chamber of the thickness of the lens. It does not alter the IOP either in normal eyes or in eyes with elevated IOP. The rate of pupillary constriction may be slightly slower in clients with brown irises than in clients with blue or green irises.

Dapiprazole Absorption

Systemic absorption is negligible.

Dapiprazole side effects and Toxicity

Oral LD50 is 1189—2100 mg/kg in mice, rats and rabbits.

Dapiprazole Patient Information

Dapiprazole Organisms Affected

Humans and other mammals